8-K current report · filed Aug 19, 2026

Twist Bioscience Corp (TWST) 8-K Current Report: August 19, 2026

Item 7.01TWST overview

Short answer

Twist Bioscience Corp (TWST) filed an 8-K current report with the SEC on August 19, 2026 reporting Item 7.01 (Regulation FD Disclosure). Anthropic selected Twist as an independent evaluator for AI-designed protein production and binding tests.

Twist Bioscience Corp 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Anthropic selected Twist as an independent evaluator for AI-designed protein production and binding tests
  • Campaign spans 15 protein targets using Claude Opus 4.8 and Mythos Preview
  • Strategic validation of Twist’s rapid, scaled DNA synthesis and protein-testing capabilities
  • Potential demand upside from AI-enabled drug discovery, though financial terms and commercial commitments remain unspecified

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Twist Bioscience Corp 8-K filings

Get the next TWST 8-K as it lands

Follow TWST for push alerts, or ask the research agent what this filing means.